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OBJECTIVES The study evaluated the safety and efficacy of stent reconstruction of stenotic/occluded
iliofemoral veins (IFV) and inferior vena cava (IVC).
BACKGROUND Patients with congenital heart defects and stenotic or occluded IFV/IVC may encounter
femoral venous access problems during future cardiac surgeries or catheterizations.
METHODS Twenty-four patients (median age 4.9 years) underwent implantation of 85 stents in 22 IFV
and 6 IVC. Fifteen vessels were severely stenotic and 13 were completely occluded. Although
guide wires were easily passed across the stenotic vessels, occluded vessels required puncture
through the thrombosed sites using a stiff wire or transseptal needle. Once traversed, the
occluded site was dilated serially prior to stent implantation.
RESULTS Following stent placement, the mean vessel diameter increased from 0.9 6 1.6 to 7.4 6
2.6 mm (p , 0.05). Twenty-one of 28 vessels had long segment stenosis/occlusion requiring
two to seven overlapping stents. Repeat catheterizations were performed in seven patients (9
stented vessels) at mean follow-up of 1.6 years. Seven vessels remained patent with mean
diameter of 6.4 6 2.0 mm. Two vessels were occluded, but they were easily recanalized and
redilated. Echocardiographic follow-up in two patients with IVC stents demonstrated wide
patency. In four additional patients, a stented vessel was utilized for vascular access during
subsequent cardiac surgery (n 5 3) and endomyocardial biopsy (n 5 1). Therefore, 13 of 15
stented vessels (87%) remained patent at follow-up thus far.
CONCLUSIONS Stenotic/obstructed IFV and IVC may be reconstructed using stents to re-establish venous
access to the heart for future cardiac catheterization and/or surgeries. (J Am Coll Cardiol
2001;37:251–7) © 2001 by the American College of Cardiology
Repeated cardiac catheterization or indwelling femoral lines
following cardiac surgery may result in severe stenosis or
complete occlusion of the iliofemoral vein (IFV) and/or
inferior vena cava (IVC). Vascular access from the iliofem-
oral venous system for future cardiac catheterization or
surgery may be compromised. This limitation of vascular
access is particularly problematic in infants and young
children with congenital heart disease who may require
multiple cardiac surgeries and/or diagnostic and interven-
tional cardiac catheterizations. The purpose of this study
was to assess the feasibility of treating IFV and IVC
stenoses or occlusions with intravascular stents in order to
maintain vascular patency for future cardiac catheterization
and surgery. Immediate and limited intermediate-term re-
sults of the patency of the stented veins are reported.
METHODS
During cardiac catheterization from May 1992 to June
1999, patients with a stenotic or occluded IFV and/or IVC
who will need future cardiac catheterization or surgery were
identified. Only those vessels cannulated and stented were
included in this study. Angiographic data of the stented
vessels was analyzed. Both pre- and post-stent minimum
vessel diameters were compared using a paired Student
t-test. Pressure gradients were invariably absent because of
adequate venous collateral flow in the presence of a low-
pressure system and hence were not included in our evalu-
ation. All patients were treated with aspirin empirically for
at least six months following stent implant. Stent patency
was evaluated at subsequent cardiac catheterization or sur-
gery. In addition, IVC stents were evaluated with two-
dimensional (2-D) and Doppler echocardiography at the
time of clinic follow-up.
Technique. Stents were implanted in the obstructed or
occluded vessels using standard techniques (1–5). Modifi-
cations were made based on the specific vessel affected and
whether severe stenosis or complete occlusion was found.
Iliofemoral veins. If an IFV was severely stenotic but not
occluded, an end hole catheter was advanced across the
affected vessel and exchanged for a superstiff guide wire.
Balloon dilation was performed initially to permit passage of
a Mullins sheath (Cook, Bloomington, Indiana) for stent
delivery and implantation.
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If an IFV was completely occluded, the first indication
was usually the inability to pass a wire into the IVC even
though there was blood return through the percutaneous
needle. A hand injection into the needle reveals venous
collaterals draining into the paravertebral venous system.
When this problem was encountered, careful review of the
angiogram with emphasis on the very early phase of the
injection in both the anteroposterior (AP) and lateral
projections often revealed a small, tapering blind-end rem-
nant of the superficial femoral vein (Fig. 1A). It is preferable
to film the hand injection at 60 frames/s but no less than 30
frames/s to ensure recognition of this vessel remnant before
the venous collaterals superimpose upon the occluded fem-
oral vessel in the AP projection (Fig. 1B). This femoral vein
remnant is easily missed because the remnant may be
present in only one or two frames. The lateral projection is
particularly useful because the femoral vein remnant takes
an anterior course in contrast to the more posteriorly
positioned paravertebral venous collaterals (Fig. 1C).
Once this vessel remnant was identified, an 0.018- or
0.025-in. (0.045- or 0.063-cm) stiff straight wire such as a
Glidewire or the stiff end of a Teflon wire was advanced
through the percutaneous needle as far into the vessel as
possible. The percutaneous needle was exchanged for a
4–5F tapered dilator, which was also advanced as far as
possible. The stiff dilator prevents buckling of the wire
during its advancement. With the support of the stiff
dilator, the wire was pushed into the occluded vessel in
millimeter increments. A still-frame image from the angio-
gram was used as a roadmap to facilitate this procedure.
Each time the wire was advanced further, the dilator was
also advanced further over the wire. Keeping the dilator in
place, the wire was removed and a small hand injection of
contrast was performed into the dilator to assess for extrav-
asation (Fig. 2). Often, contrast stains the surrounding
thrombus defining the lumen of the occluded vessel. Mul-
tiple hand injections were performed until the wire traversed
the occluded segment and contrast flowed freely in an
unobstructed proximal segment of the vessel (Fig. 3). Once
the dilator recanalized the occluded vessel, a stiff exchange
length guide wire such as a Platinum Plus wire (Boston
Scientific, Watertown, Massachusetts) was advanced
through the dilator into the proximal IVC and the occluded
vessel was serially dilated using dilators or balloons until the
vessel lumen was large enough to accommodate a 7–9F
Mullins sheath for stent delivery (Fig. 4). When a single
stent was inadequate to cover the entire length of the
stenotic segment, multiple overlapping stents were used
(Fig. 5). To ensure the stents did not separate during
expansion, at least a 2-mm portion was overlapped. A final
injection of contrast into the stented vessel was performed
to evaluate flow and residual venous collaterals (Fig. 6).
Often, the diagnostic component of the cardiac catheteriza-
tion was carried out through the long Mullins sheath before
proceeding with stent implantation of the occluded vessel.
During stent implantation of the femoral veins, a clamp
was positioned on the surface of the groin corresponding to
the level of the inguinal ligament defining the caudal limit
for stent implantation (Fig. 5). A percutaneous needle was
also left on the surface of the groin, parallel to the course of
the femoral vein, to determine the level at which the tip of
the needle may enter the stent (Fig. 7). Often, the most
caudal edge of the stent was positioned such that its inferior
edge would permit entrance with a femoral percutaneous
needle. This strategy was designed to allow recanalization
with a needle should the stent become occluded in the
future. Using the AP and lateral projections, one can
advance a percutaneous needle into an occluded vessel as
Abbreviations and Acronyms
AP 5 anteroposterior
IFV 5 iliofemoral vein
IVC 5 inferior vena cava
Figure 1. (A) This 5.3-kg infant with hypoplastic left heart syndrome s/p Norwood I operation underwent a pre-Glenn catheterization. Hand injection
of contrast demonstrated complete occlusion of the left iliofemoral venous system, with contrast entering the paravertebral venous collateral circulation. (B)
Careful evaluation of the early phase of the same injection demonstrated a tiny superficial femoral vein remnant (arrow) before filling by the superimposed
paravertebral venous collaterals. (C) The same injection on the lateral projection showed the anterior position of the femoral vein remnant (arrow) compared
to the posterior paravertebral collateral veins.
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defined by the lumen of the stent. Further advancement
with a wire within the stent will ensure no extravasation. On
the lateral projection, the most caudally implanted stent was
positioned such that it was not anterior to the bladder. The
level of the most caudal edge of the stent was in the
mid-portion of the bladder. At the end of the procedure, the
hips were flexed to assess the stent position on the lateral
projection (Fig. 8). This maneuver documented the absence
of stent movement during hip flexion.
Inferior vena cava. The technique of stent implantation of
stenotic IVC was similar to stenotic IFVs with one addi-
tional caveat. Hand injections of contrast were used to
evaluate stent position in relationship to the renal vein
orifices so as to avoid overlap (Fig. 9). Fortunately, IVC
obstructions usually occurred distal to the entrance of the
renal veins and not at the interrenal vein segment.
If a completely occluded IVC was encountered, a sheath
was inserted into the right internal jugular vein and a second
catheter was advanced through the right atrium to the site of
the IVC occlusion. With the catheter positioned in the
distal IVC as a “target,” a transseptal needle, Mullins sheath,
and a dilator (Cook, Bloomington, Indiana) were advanced
from the femoral vein directed toward the “target” catheter
superiorly under fluoroscopic guidance in both AP and
Figure 2. Through a 4F dilator, a stiff 0.018-in. (0.0457-cm) wire was
carefully pushed into the occluded vessel in millimeter increments followed
by advancement of the dilator. The wire and dilator should follow the
expected course of the IFVs in both AP and lateral projections. Contrast
was hand-injected into the dilator after the wire was removed, demonstrat-
ing no extravasation. Note the length of the occluded segment, which
extended from the left superficial femoral vein to the midportion of the
IVC just below the renal veins (arrows).
Figure 3. The wire and dilator were advanced beyond the occluded
segment. Contrast flowed freely into the patent IVC and the renal veins
(arrow).
Figure 4. An exchange guide wire was passed across the recanalized vessel,
and balloon dilation of the entire occluded segment was carried out
initially.
Figure 5. Seven overlapping stents were implanted. A clamp was placed on
the surface of the groin corresponding to the level of the inguinal ligament
(dashed line), which defined the caudal limit for stent implant. The three
most inferior overlapping stents are shown here.
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lateral projections. To evaluate for extravasation, small
increments of needle advancement were followed by small
hand injections of contrast into the needle. Once contrast
was seen to flow freely within the IVC beyond the occluded
segment, the long sheath and dilator were advanced ceph-
alad across the occluded segment. The needle was removed
and an exchange guide wire was inserted into the dilator and
used for balloon dilation and stent implantation.
RESULTS
Patient profile. Twenty-four patients were included in our
study. The median age was 4.9 years (range 0.2 to 12 years)
and weight was 15.9 kg (range 5.3 to 41.6 kg). Bilateral IFV
occlusion or obstruction was found in 10 patients. A
unilaterally affected iliofemoral venous system was seen in
11 patients. The IVC occlusion or obstruction was identi-
fied in six patients, three of whom had combined IFV and
IVC obstruction.
Indications for stent implantations included the need for
additional cardiac catheterizations (12 patients) and future
cardiac surgery (11 patients). One patient who developed
acute renal failure and hepatic dysfunction two days follow-
ing cardiac surgery required a stent to open an acute
proximal IVC occlusion.
Figure 6. Post-stent implant angiogram demonstrated wide patency from
the IFV system to the proximal IVC. Notice that the previously seen
paravertebral collateral flow was no longer present.
Figure 7. A percutaneous needle was placed on the skin surface parallel to
the femoral vein in order to determine the level at which the most caudal
stent must be implanted and still permit access into the stent by the needle.
This strategy will permit recanalization of the stent by a needle (arrow) in
the event that it is completely occluded in the future.
Figure 8. At the end of the procedure, the hips were flexed (black arrow)
under lateral fluoroscopy to evaluate for potential stent movement. In this
patient, five overlapping stents were implanted from the right IFV to the
IVC. Hip flexion did not change the position of the most caudal stent
(white arrow).
Figure 9. Contrast injection into the IVC was used to evaluate stent
position relative to the renal vein orifices (arrows) to avoid overlap.
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Stent data. Eighty-five Palmaz stents (Johnson & Johnson
Interventional Systems, Warren, New Jersey) were im-
planted in 28 vessels in 24 patients. Severe stenosis was
present in 15 vessels, while complete occlusion was encoun-
tered in 13 vessels. Eighteen right IFVs received 65 stents
and four left IFVs received 12 stents. In the IVC, seven
stents were implanted in six vessels (4 occluded, 2 severely
stenotic). Stents used included the Palmaz P-154, P-204,
P-294, P-394, and P-308. No complications were encoun-
tered during the stent procedures in 23 patients. In one
patient, mild extravasation of contrast was noted during
passage of the wire across an occluded left IFV. However,
the vessel was successfully traversed and stented without
subsequent problems.
The mean minimum diameter of the vessels before the
stent procedure was 0.9 6 1.6 mm increasing to 7.4 6
2.6 mm after stent placement (p # 0.0001). Long segment
stenoses or obstructions were found in 21 of 28 vessels
(75%), which required two to seven overlapping stents.
Follow-up. To date, follow-up data was available on 15 of
28 stents (12 of 24 patients). Cardiac catheterization was
performed in nine stented vessels (7 patients) at median
follow-up of 0.92 years (range 0.44 to 2.17 years). These
vessels included right IFV (4 patients), left IFV (2 patients),
and IVC (3 patients). Seven stented vessels were widely
patent and lined with a neo-intimal layer measuring 0.5 to
2.8 mm in thickness (mean 1.3 mm). Two stented vessels
were completely occluded, one of which was a stented IVC
with a large venous collateral bypassing the stented segment.
Interestingly, this patient also had a stented left femoral vein
that remained widely patent. The second occluded vessel at
follow-up was a stented left IFV. This particular patient
originally had an occlusion in the left IFV that extended
into the distal IVC and who received several overlapping
stents. Fortunately, the distal IVC stent remained patent
with venous collaterals entering into the stented segment of
the IVC. In both patients, the occluded stents were recana-
lized using a stiff wire and redilated using additional stents.
Three patients underwent cardiac surgery between one
week and 12 months following the stent procedure. At the
time of surgery, the stented vessels were cannulated and
used for central access. In addition, a stented vessel in a
post–cardiac transplant patient was utilized for repeated
endomyocardial biopsies. Although no angiograms were
performed to confirm patency of these stented vessels, the
fact that they were successfully cannulated would imply
patency.
In two patients with IVC stents, echocardiographic
follow-up was obtained at 25.2 and 51 months after
implant. Both stents were in good position, and IVCs
remained widely patent as demonstrated by 2-D and Dopp-
ler imaging. Therefore, 13 of 15 stented vessels (87%) were
found to be patent at follow-up. Two occluded vessels were
successfully recanalized and redilated. Recanalization was
facilitated by presence of the stent within the vascular
lumen.
DISCUSSION
Obstructed IFV and IVC: Causes, symptoms, and inci-
dence. In children with congenital heart defects, iliofemo-
ral venous stenosis or occlusion may result from prolonged
indwelling catheters following cardiac surgery or repeated
use for cardiac catheterization. In cases where catheter-
based interventions are performed, often larger sheaths are
necessary. When these procedures are performed in infants
and young children, the iliofemoral venous system is highly
susceptible to the development of stenosis or occlusion.
Occasionally, the distal IVC also becomes stenotic or
occluded, as seen in our cohort. Except for an occasional
dilated superficial vein noted in the lower abdomen and
pelvic region, a stenotic or occluded IFV is usually not
accompanied by any clinical signs or symptoms. The deep
femoral veins remain patent and venous collaterals will drain
blood from the affected leg via the paravertebral venous
system to the proximal IVC, often at the level of the renal
veins. Therefore, true incidence of iliofemoral vein obstruc-
tion is not known. Although no data indicate that leg
growth and development are compromised by a stenotic or
occluded IFV, access to the heart from the superficial
femoral vein may become limited if not impossible. In
contrast to children with congenital heart disease, IVC
obstruction presenting in adults is primarily due to abdom-
inal and pelvic malignancies, and results in IVC syndrome
(leg pain, edema, venous ulceration) (6). Surgical revascu-
larization is often ineffective, and angioplasty alone exhibits
a high restenosis rate (7–10).
Stent use of congenital heart disease. The use of intra-
vascular stents for a variety of vascular stenoses in congenital
heart disease is well established (1–5,11–20). Mullins et al.
and others have reported the safe and effective use of the
Palmaz stent to treat stenoses in branch pulmonary arteries
and large systemic and pulmonary veins (1–5,11–15). Stent
implantation to maintain patency of the ductus arteriosus
and stent dilation of renal artery stenosis, coarctation of the
aorta and various surgically created baffles have also been
reported (16–20). Though there is literature on stent
dilation of stenotic IVC (21,22), there are only scant reports
documenting the use of stents to treat obstructed IFVs in
adults (6), and to our knowledge there are no reports of
recanalization and stent implantation for a completely
occluded IVC or IFV. This is particularly important in
patients with congenital heart disease who require femoral
venous access for future cardiac surgeries and/or cardiac
catheterizations. Furthermore, many of the interventional
catheterizations performed in this group of patients require
more than one venous access.
Alternative vascular access. When obstructed IFVs are
encountered during a cardiac catheterization, alternative
vascular access is available. Access to the heart from the
internal jugular vein can be easily performed, but manipu-
lation of catheters from the neck is more difficult, and the
patient’s airway may be compromised during the procedure.
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Larger sheaths required for interventional procedures and
additional radiation to the operator render the internal
jugular vein route less desirable. Others have reported
alternative access to the heart, including the transhepatic
and translumbar route (23–27). Direct transthoracic punc-
ture to the heart has also been reported (28–30). All of these
techniques have higher risks and potential complications.
Therefore, recanalizing and maintaining femoral vein pa-
tency using stents would be highly desirable in patients who
will require additional cardiac surgeries or catheterizations.
Anticipation and preparation for obstructed femoral
venous access. Due to the lack of symptoms in obstructed
IFVs, the physician performing cardiac catheterizations is
often unprepared to treat this vascular problem. Typically,
one encounters this complication at the time of a routine
cardiac catheterization when, during venous access at-
tempts, the needle “draws” blood, but the guide wire cannot
be advanced. The diagnosis of femoral venous stenosis or
occlusion is confirmed only by a hand injection of contrast
into the needle under fluoroscopy. When the paravertebral
collateral venous flow is noted, further attempts to gain
access from the affected leg are abandoned and the con-
tralateral leg or another venous route is used. For routine
diagnostic catheterization, single femoral venous access is
adequate. However, this can be problematic when more
than one venous access site is necessary for certain interven-
tional procedures or when the contralateral IFV is also
compromised. Hence, anticipation and preparation for re-
pair of this type of vascular stenosis is important, especially
in patients in whom cardiac surgeries and/or catheteriza-
tions were carried out at a young age.
Whenever a remnant of an occluded superficial femoral
vein is encountered (prior to superimposition by the contrast
in the paravertebral veins), our experience has indicated
successful recanalization in all cases. Even when no remnant
is found, recanalization using the previously described tech-
nique is still possible, but not in all cases. Because this was
a retrospective study, the success rate in recanalization of an
occluded femoral vein without a remnant vessel remains
undetermined. Based on our experience, we estimate an
approximate 60% success rate. In the “nonsuccessful” group,
we simply could not traverse the occluded segment and
proceeded with an alternative route of access to the heart.
No complications were encountered in the attempts at
recanalization.
Follow-up and future concerns. Long-term patency of
these stented vessels has not been determined at this time.
However, the most caudally implanted stent is positioned
such that a percutaneous needle can reach the most inferior
edge of the stent. In the event the stent becomes completely
occluded, under biplane fluoroscopic guidance, a needle can
recanalize an occluded intravascular stent without risk of
extravasation. This was demonstrated in two patients in
whom stent occlusion was found at routine follow-up
cardiac catheterization. Both stents were recanalized and
redilated successfully, and access to the heart was achieved
for cardiac catheterization.
Another concern is the potential for further dilation after
stent implantation as the child grows. Although we do not
have data on further dilation of stents in the IFVs and the
IVC, further dilation of implanted stents in the other vessels
has been reported in both animal and clinical studies
(30–32).
Conclusions. In summary, a stenotic or occluded IFV or
IVC can be traversed with a wire and dilated with a stent
safely and effectively. The stented vessels can provide venous
access for future cardiac catheterization or surgery. The
majority of IFV and IVC stents (87%) have remained patent
at intermediate-term follow-up. Those stents that have
become occluded can be easily recanalized and redilated to
re-establish venous access to the heart.
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